Clinical trial

WATS3D for the Detection of Esophageal Dysplasia

NCT03008980 · CDx Diagnostics, Industry · Completed

Key facts

NCT number NCT03008980
Title WATS3D for the Detection of Esophageal Dysplasia
Official title Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Analysis (WATS) for the Detection of Esophageal Dysplasia: A Prospective, Randomized, Tandem Study
Lead sponsor CDx Diagnostics, Industry
Collaborators Rockford Gastroenterology Associates Icahn School of Medicine at Mount Sinai Temple University University of Rochester University of Kansas Medical Center NYU Langone Health
Status Completed
Study type Observational
Conditions Barrett Esophagus, Esophageal Dysplasia, Esophagus Adenocarcinoma
Intervention type Other
Interventions Diagnostic Test
Enrollment 160
Start date May 1, 2014
Primary completion Jan 1, 2015
Completion Dec 1, 2018
First posted Jan 4, 2017
Last update posted Nov 4, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies